Compare Kindstar Globalgene Technology, Inc. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a -221.42% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -7.40 times
2
Flat results in Dec 25
3
Risky -
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
HKD 1,145 Million ()
NA (Loss Making)
NA
0.00%
-0.42
-3.23%
0.38
Revenue and Profits:
Net Sales:
278 Million
(Quarterly Results - Dec 2020)
Net Profit:
-880 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.78%
0%
-6.78%
6 Months
-12.7%
0%
-12.7%
1 Year
-18.52%
0%
-18.52%
2 Years
-31.68%
0%
-31.68%
3 Years
-36.42%
0%
-36.42%
4 Years
-51.54%
0%
-51.54%
5 Years
0%
0%
0.0%
Kindstar Globalgene Technology, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.30%
EBIT Growth (5y)
-221.42%
EBIT to Interest (avg)
4.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.43
Sales to Capital Employed (avg)
0.35
Tax Ratio
8.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.06%
ROE (avg)
1.39%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.39
EV to EBIT
0.01
EV to EBITDA
0.02
EV to Capital Employed
-0.00
EV to Sales
-0.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-1.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,012.50
1,005.70
0.68%
Operating Profit (PBDIT) excl Other Income
-63.10
-53.90
-17.07%
Interest
18.20
14.90
22.15%
Exceptional Items
38.40
-22.30
272.20%
Consolidate Net Profit
-59.80
-65.80
9.12%
Operating Profit Margin (Excl OI)
-175.30%
-132.90%
-4.24%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.68% vs -5.90% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 9.12% vs -263.28% in Dec 2024
About Kindstar Globalgene Technology, Inc. 
Kindstar Globalgene Technology, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






